Jubilant Pharmova Quarterly Results for Trading Insights
JUBLPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹120 Cr
QSept 2025
Jubilant Pharmova Quarterly Results Key Highlights
- Revenue of ₹1,968 Cr in Sept 2025 (+2.1% vs Mar 2025, +11.6% vs Sept 2024)
- Net Profit of ₹120 Cr in Sept 2025 (-20.5% vs Mar 2025, +16.5% vs Sept 2024)
- EBITDA of ₹337 Cr in Sept 2025 (-1.2% vs Mar 2025)
- Operating Margin of 17.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹7.59 in Sept 2025 (-21.8% vs Mar 2025)
Jubilant Pharmova Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,968 | 1,928 | 1,891 | 1,764 | 1,764 | 2.1% | 11.6% |
| Net Profit (₹ Cr) | 120 | 151 | 103 | 103 | -62 | - | - |
| EBITDA (₹ Cr) | 337 | 341 | 280 | 287 | 108 | - | - |
| EPS (₹) | 7.59 | 9.71 | 6.49 | 6.47 | -3.69 | - | - |
| Operating Margin (%) | 17.0% | 17.0% | 14.0% | 15.0% | 5.0% | - | - |
Jubilant Pharmova Share Price Trend Around Quarterly Results
Visualize Jubilant Pharmova's 1-year price movement across quarterly results — ideal for logging trades in Jubilant Pharmova share price
chart using Tickjournal. All values in ₹.
Related Pages for Jubilant Pharmova
Additional stock information and data for JUBLPHARMA
Revenue Trend (₹ Cr)
Sept 2024
1,764
Jun 2025
1,891
Mar 2025
1,928
Sept 2025
1,968
Net Profit Trend (₹ Cr)
Sept 2024
103
Jun 2025
103
Mar 2025
151
Sept 2025
120
Operating Margin Trend (%)
Sept 2024
15.0%
Jun 2025
14.0%
Mar 2025
17.0%
Sept 2025
17.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Jubilant Pharmova quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores